This chronic inflammation in tumours promotes the accumulation of T-cell-suppressive neutrophils and other immunosuppressive cells through the continuous release of protumour inflammatory factors, which is consistent with the conclusion that ANXA2 mediates IL-1β production and promotes tumour immune suppression [159]. This evidence concerns the gene ANXA2 and neoplasm.